Inventor · disambiguated record
Yunfeng Cheng
Also filed as: CHENG YUNFENG
6 granted patents·2 pending applications·6 citations·filing 2008–2023
72Inventor score
Files withUNIV LELAND STANFORD JUNIOR3HANGZHOU WESTAN PHARMACEUTICAL TECH CO LTD2TEXAS A & M UNIV SYS2WANG BINGHE1
Top patents by PatentIndex Score
8 records- 0184US9834681B22,7-disubstituted cephalosporin derivatives as beta-lactamase substrates and methods for their use for the diagnosis of tuberculosisTEXAS A & M UNIV SYS·Filed 2015·Granted Dec 5, 2017·4 cites·33 claims
- 0272US11679168B2Caspase-3-triggered molecular self-assembling PET probes and uses thereofUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Jun 20, 2023·1 cites·3 claims
- 0363US2024042068A1Caspase-3-triggered molecular self-assembling pet probes and uses thereofUNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 0461US8653258B2Compositions for regulating or modulating quorum sensing in bacteria, methods of using the compounds, and methods of regulating or modulating quorum sensing in bacteriaWANG BINGHE·Filed 2008·Granted Feb 18, 2014·1 cites·6 claims
- 0560US10344165B22,7-disubstituted cephalosporin derivatives as β-lactamase substrates and methods for their use for the diagnosis of tuberculosisTEXAS A & M UNIV SYS·Filed 2017·Granted Jul 9, 2019·0 cites·19 claims
- 0641US2023357218A1N-formamidopyrazoline derivative as p2x3 receptor antagonist and use thereofHANGZHOU WESTAN PHARMACEUTICAL TECH CO LTD·Filed 2021·Application pending·0 cites
- 0739US12391660B2Heteroaromatic acetamide derivative, and preparation and use thereofHANGZHOU WESTAN PHARMACEUTICAL TECH CO LTD·Filed 2020·Granted Aug 19, 2025·0 cites·6 claims
- 0834US10370538B2Probes for rapid and specific detection of mycobacteriaUNIV LELAND STANFORD JUNIOR·Filed 2016·Granted Aug 6, 2019·0 cites·6 claims
Join the waitlist — get patent alerts
Get an alert when Yunfeng Cheng files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →